EP4433065
USE OF MARIBAVIR FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION AND TREATMENT REGIMENS THEREOF
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
18.11.2022EP published:
11.3.2026EP application number:
22826859.5
EPO information:
European Patent Register
Max expiry date:
17.11.2042Expiry date:
17.11.2026
Title in English:
USE OF MARIBAVIR FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION AND TREATMENT REGIMENS THEREOFLanguage of the patent:
English
Timeline
Today
18.11.2022EP application
11.3.2026EP Publication
17.11.2026Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
Inventor
Name:
SONG, HengAddress:
Lexington, MA 02421, US
Name:
SUN, KefengAddress:
Lexington, MA 02421, US
Name:
CROUTHAMEL, MatthewAddress:
Lexington, MA 02421, US
Name:
CHEN, GraceAddress:
Lexington, MA 02421, US
Name:
ZHU, Andy Z.X.Address:
Lexington, MA 02421, US
Name:
MICHON, Ingrid NicolleAddress:
Princeton, NJ 08540, US
Name:
BURT, Howard JamesAddress:
Princeton, NJ 08540, US
Name:
BARTER, Zoe ElizabethAddress:
Princeton, NJ 08540, US
Name:
NEUHOFF, SibylleAddress:
Princeton, NJ 08540, US
Priority
Number:
202163281206 PDate:
19.11.2021Country:
US
Classification
Categories:
A61K 31/7056, A61K 45/06, A61P 31/22